IP Library › Granted Patent US 6,877,514
Granted Patent B2
US 6,877,514 · App. 10/696,127 · Granted Apr 12, 2005

Mixed chimerism and tolerance

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,877,514
App. No.
10/696,127
Granted
Apr 12, 2005
Kind
B2
Abstract

A method of inducing tolerance without whole body irradiation.

Claims (16)

1. A method of promoting tolerance in a recipient mammal to an allograft obtained from a donor mammal of the same species comprising:

(a) introducing hematopoietic stem cells of said donor mammal into said recipient mammal;

(b) creating thymic space in said recipient;

(c) depleting or lysing donor-reactive T cells of said recipient mammal; and

(d) introducing said graft into said recipient mammal,

wherein the number of donor stem cells administered is sufficient such that mixed chimerism can be formed without hematopoietic space-creating irradiation.

2. The method of claim 1 , wherein said mixed chimerism is formed in the absence of hematopoietic space created by whole body irradiation.

3. The method of claim 1 , wherein said recipient is a human.

4. The method of claim 1 , wherein said thymic space is created by administering to the recipient at least one treatment selected from the group consisting of thymic irradiation, steroids, corticosteroids, brequinar, or an immune suppressant chemical or drug.

5. The method of claim 1 , wherein said thymic space is created by administering thymic irradiation to said recipient.

6. The method of claim 1 , wherein said thymic space is created by administering an immune suppressant chemical or drug to the recipient.

7. The method of claim 1 , wherein said thymic space is created by administering a short course of cyclosporin to said recipient.

8. The method of claim 1 , wherein multiple hematopoietic stem cell administrations are provided to said recipient.

9. The method of claim 1 , further comprising inactivating donor-reactive NK cells of said recipient mammal.

10. The method of claim 1 , wherein said graft comprises a kidney.

11. The method of claim 1 , wherein said graft comprises a liver.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: SYKES, MEGAN
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 036780/0653 →
Continuity (5)
Division 1015587800 · May 24, 2002
Division 0937449800 · Aug 13, 1999
Division 0885570500 · May 8, 1997
Provisional Application 6001709900 · May 9, 1996
Related Publication 20040247579A1 · Dec 9, 2004